Skip to content
lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nurix Therapeutics, Inc.
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress
May 20, 2026
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
May 8, 2026
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 6, 2026
Nurix Therapeutics to Participate in Upcoming Investor Conference
May 6, 2026
←
Previous Page
1
2